These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 25545782)
1. Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model. Plengsuriyakarn T; Karbwang J; Na-Bangchang K Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):293-304. PubMed ID: 25545782 [TBL] [Abstract][Full Text] [Related]
2. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. Srijiwangsa P; Ponnikorn S; Na-Bangchang K BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576 [TBL] [Abstract][Full Text] [Related]
3. Anticancer Activity of Atractylodes lancea (Thunb.) DC in a Hamster Model and Application of PET-CT for Early Detection and Monitoring Progression of Cholangiocarcinoma. Plengsuriyakarn T; Matsuda N; Karbwang J; Viyanant V; Hirayama K; Na-Bangchang K Asian Pac J Cancer Prev; 2015; 16(15):6279-84. PubMed ID: 26434829 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activities and effects of atractylodin and β-eudesmol on the cell cycle arrest and apoptosis on cholangiocarcinoma cell line. Kotawong K; Chaijaroenkul W; Muhamad P; Na-Bangchang K J Pharmacol Sci; 2018 Feb; 136(2):51-56. PubMed ID: 29525035 [TBL] [Abstract][Full Text] [Related]
5. Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract. Amuamuta A; Plengsuriyakarn T; Na-Bangchang K BMC Complement Altern Med; 2017 Apr; 17(1):213. PubMed ID: 28403856 [TBL] [Abstract][Full Text] [Related]
6. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis. Hu JH; Tang JH; Lin CH; Chu YY; Liu NJ J Investig Med; 2018 Jan; 66(1):52-61. PubMed ID: 28912249 [TBL] [Abstract][Full Text] [Related]
7. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET. Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis. Annunziata S; Caldarella C; Pizzuto DA; Galiandro F; Sadeghi R; Giovanella L; Treglia G Biomed Res Int; 2014; 2014():247693. PubMed ID: 24955351 [TBL] [Abstract][Full Text] [Related]
10. Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models. Plengsuriyakarn T; Viyanant V; Eursitthichai V; Picha P; Kupradinun P; Itharat A; Na-Bangchang K BMC Complement Altern Med; 2012 Mar; 12():23. PubMed ID: 22448640 [TBL] [Abstract][Full Text] [Related]
11. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454 [TBL] [Abstract][Full Text] [Related]
12. Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of Atractylodes lancea (Thunb.) DC. Plengsuriyakarn T; Kotawong K; Karbwang J; Na-Bangchang K BMC Complement Med Ther; 2023 Jun; 23(1):186. PubMed ID: 37287012 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372 [TBL] [Abstract][Full Text] [Related]
14. The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma. Moon CM; Bang S; Chung JB Surg Oncol; 2011 Mar; 20(1):e10-7. PubMed ID: 19804967 [TBL] [Abstract][Full Text] [Related]
15. Growth inhibitory effect of β-eudesmol on cholangiocarcinoma cells and its potential suppressive effect on heme oxygenase-1 production, STAT1/3 activation, and NF-κB downregulation. Mathema VB; Chaijaroenkul W; Karbwang J; Na-Bangchang K Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1145-1154. PubMed ID: 28732110 [TBL] [Abstract][Full Text] [Related]
16. The anticancer effects of Resina Draconis extract on cholangiocarcinoma. Wen F; Zhao X; Zhao Y; Lu Z; Guo Q Tumour Biol; 2016 Nov; 37(11):15203-15210. PubMed ID: 27683055 [TBL] [Abstract][Full Text] [Related]
19. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. Petrowsky H; Wildbrett P; Husarik DB; Hany TF; Tam S; Jochum W; Clavien PA J Hepatol; 2006 Jul; 45(1):43-50. PubMed ID: 16690156 [TBL] [Abstract][Full Text] [Related]
20. β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation. Acharya B; Chajaroenkul W; Na-Bangchang K Asian Pac J Cancer Prev; 2022 Aug; 23(8):2573-2581. PubMed ID: 36037109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]